GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms ...
Advertisers keep counting on Julie Bowen and Ty Burrell to reach out from “Modern Family” to yours. The duo, currently ...
Issued on behalf of GT Biopharma, Inc.From bispecific ADCs at IDEAYA to a GSK partnership at Summit, B7-H3 has become one of the most actively ...
With more than 2,000 industry professionals, Veeva Commercial Summit is the largest commercial and medical event in North America. More than 40 sponsoring partners include Accenture, Conexus, ...
New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the ...
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by ...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best healthcare stocks to buy for the long term. Halozyme ...
The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed ...
Britain's GSK said on Monday it signed a deal with Hong Kong-listed Sino Biopharmaceutical to expand its presence in the ...
With Siran Biotechnology under its fold, GSK will have access to a long-acting siRNA therapy that could induce weight loss while preserving lean mass, in addition to addressing other weight-related ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results